- TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q2 earnings results on Monday, August 4th, before market open.
- The consensus EPS Estimate is $0.29 and the consensus Revenue Estimate is $146.27M (+99.1% Y/Y).
- Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward.
- Revenue estimates have seen 4 upward revisions and 1 downward.
TG Therapeutics Q2 2025 Earnings Preview
